Literature DB >> 7216447

Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.

K K Matthay, W C Mentzer, D W Wara, H K Preisler, N B Lameris, A J Ammann.   

Abstract

A luminol-enhanced chemiluminescence assay was used to investigate opsonic requirements for phagocytosis of STreptococcus pneumoniae serotypes VII, XIV, and XIX. After opsonization with whole immune sera (with antibody and total complement pathway), heat-inactivated immune sera (with antibody alone), or magnesium dichloride-ethylene glycol tetraacetic acid-chelated immune sera (with antibody and alternative complement pathway), live S. pneumoniae cells were incubated at 37 degrees C with normal polymorphonuclear leukocytes while serial chemiluminescence measurements were recorded. The amount of chemiluminescence observed correlated closely with evidence of phagocytosis as observed by microscopy. Complement was required for efficient opsonization, since all three serotypes showed a slower rise and less integral chemiluminescence after opsonization with heat-inactivated serum as compared with whole serum. The alternative pathway provided opsonic activity equal to that of the total complement pathway for type XIX, but only intermediate activity for types VII and XIV. Type-specific antibody was also required for effective opsonization of all three serotypes since chemiluminescence was markedly reduced when bacteria were opsonized with antibody-depleted serum (serum absorbed with type-specific S. pneumoniae cells at 4 degrees C). Thus, chemiluminescence proved to be an effective means of defining the requirement for both antibody and complement in the opsonization and phagocytosis of S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216447      PMCID: PMC351774          DOI: 10.1128/iai.31.1.228-235.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children.

Authors:  F A Loda; A M Collier; W P Glezen; K Strangert; W A Clyde; F W Denny
Journal:  J Pediatr       Date:  1975-12       Impact factor: 4.406

Review 3.  Pneumococcal bacteremia. Review of 111 cases, 1957--1969, with special reference to cases with undetermined focus.

Authors:  J P Burke; J O Klein; H M Gezon; M Finland
Journal:  Am J Dis Child       Date:  1971-04

4.  Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.

Authors:  J A Winkelstein; R H Drachman
Journal:  N Engl J Med       Date:  1968-08-29       Impact factor: 91.245

5.  Impaired chemiluminescence during phagocytosis of opsonized bacteria.

Authors:  R L Stjernholm; R C Allen; R H Steele; W W Waring; J A Harris
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

6.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

7.  Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.

Authors:  R M Des Prez; C S Bryan; J Hawiger; D G Colley
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

8.  Influence of the alternate complement pathway in opsonization of several bacterial species.

Authors:  A Forsgren; P G Quie
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

9.  Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes.

Authors:  H Rosen; S J Klebanoff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

10.  Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G.

Authors:  R B Johnston; J E Lehmeyer; L A Guthrie
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Haemophilus influenzae type b opsonins of intravenous immunoglobulins.

Authors:  S Bender; S Hetherington
Journal:  J Clin Immunol       Date:  1987-11       Impact factor: 8.317

3.  Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.

Authors:  T Kelly; J P Dillard; J Yother
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Activation of human complement by the pneumococcal toxin pneumolysin.

Authors:  J C Paton; B Rowan-Kelly; A Ferrante
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  Early clearance of pneumococci from the lungs of decomplemented rats.

Authors:  S R Rehm; J D Coonrod
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

6.  Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes.

Authors:  P Robinson; D Wakefield; S N Breit; J F Easter; R Penny
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

7.  Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.

Authors:  Jose Yuste; Ashwin Sen; Lennart Truedsson; Göran Jönsson; Liang-Seah Tay; Catherine Hyams; Helen E Baxendale; Fiona Goldblatt; Marina Botto; Jeremy S Brown
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

Review 8.  Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

Authors:  E AlonsoDeVelasco; A F Verheul; J Verhoef; H Snippe
Journal:  Microbiol Rev       Date:  1995-12

9.  Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.

Authors:  S E Gardner; D C Anderson; B J Webb; A E Stitzel; M S Edwards; R E Spitzer; C J Baker
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

10.  Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6.

Authors:  C Mold; K M Edwards; H Gewurz
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.